Ulster University Logo

An Open Business Model approach as a framework to assess the Early Value Proposition of Emerging Healthcare Technologies

Davey, S, Brennan, M, Meenan, BJ and McAdam, Rodney (2010) An Open Business Model approach as a framework to assess the Early Value Proposition of Emerging Healthcare Technologies. In: HTAi Health Technology Assessment International, Dublin, Ireland. Health Information and Quality Authority (HIQA). 1 pp. [Conference contribution]

Full text not available from this repository.


Health service managers and industry face significant challenges in implementing and delivering innovations for healthcare. The rapidly increasing range and expense of new medical devices has created a growing need to demonstrate that a new product is superior to an existing one in terms of value (Vallejo-Torres et al, 2008).An open business model links the technical potential of a device with the latent value. Recent research has indicated that a wider perspective on the value chain for healthcare technologies could benefit companies (Davey et al, 2010).An articulation of the value proposition, that is the value created for users by the technology is the key starting point for current thinking on open and innovative business models (Chesbrough, 2006; Osterwalder, 2009) and forms a basis for their further development for appropriate evaluation of healthcare products. Conducting economic evaluations to determine value is beyond the activities of most medical device companies and clinicians, however the importance of estimating value at the early stage of technology development is increasingly being acknowledged.The aim of this research is to develop a framework for ‘valuing’ a new medical device at the concept stage that balances benefit to the healthcare provider against commercial costs. This paper explores the utilisation of the ‘headroom method’ (Cosh et. al, 2007) to derive an estimate of the economic (and/or commercial headroom) available to a new device with a particular functional profile in order to support a decision to proceed with its development. It is proposed that appropriate clinical opinion on trials and other evidence-gathering activities undertaken as part of the development process can contribute to the early stage estimates of value beneficial to both the health service and industry decision makers.

Item Type:Conference contribution (Poster)
Faculties and Schools:Faculty of Computing & Engineering
Ulster Business School > Department of Management and Leadership
Ulster Business School > Department of Marketing, Entrepreneurship and Strategy
Faculty of Computing & Engineering > School of Engineering
Ulster Business School
Research Institutes and Groups:Engineering Research Institute
Engineering Research Institute > Nanotechnology & Integrated BioEngineering Centre (NIBEC)
Business and Management Research Institute
ID Code:21580
Deposited By: Dr Shirley Davey
Deposited On:26 Mar 2012 10:51
Last Modified:08 Oct 2012 11:00

Repository Staff Only: item control page